An actively managed mutual fund focused on companies across the healthcare sector, including biotechnology, pharmaceuticals, medical devices, and healthcare services. Managed by T. Rowe Price, the portfolio emphasizes growth-oriented healthcare firms and often holds a mix of large pharmaceutical com...
1 member of Congress has disclosed 1 trade in T Rowe Price Health Science (PRHSX), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-12-17 | CHARLES J. "CHUCK" FLEISCHMANN | buy | $1K – $15K |